All Articles

Novo Nordisk Appoints Industry Veteran George Godfrey to Lead UK Medical Division

British Hospital First to Trial Novel Therapy for Rare Blood Cancer

Biotech and Software Firms Expand Global Partnership to Accelerate Antibody Research

A quiet exit from a public research agency exposes a gap the NHS cannot afford to ignore

Kent and Medway's restructuring is not a local accounting story. It is a preview of what "financial grip" now means across the health service.

NHS Specialty Roles See Dramatic Shift Toward UK-Trained Medics

Private ADHD and autism assessments have become the NHS's largest ungoverned spending line, and the coming Fonagy review will not fix that alone.

A £1.5 million Birmingham contract shows what NHS obesity care now looks like on paper, and how much still depends on what happens off it.

What a hundred tech firms admitting AI has already breached their own defences should mean for the NHS.

Nvidia's record quarter shows how far the health service's AI ambitions now depend on infrastructure it neither owns nor controls.

The Care Quality Commission's latest inpatient survey shows a health service coping unevenly with pressure, and the unevenness has a shape.

The UCLH pituitary operation shows what real-time clinical AI can do, and how far the rules built for it still have to travel.

Norfolk and Suffolk's advance to full mobilisation on its SystmOne rollout sits alongside trusts at earlier and more precarious stages of the same journey, exposing how unevenly digital maturity is spreading across the service just as its national overseer prepares to disappear.

A report built on three thousand complaints exposes commissioning failure just as the government prepares to decide what drives England's neurodevelopmental backlog.

Years of reluctance over Palantir's hold on NHS patient records coexist oddly with a quick deal to exchange UK expertise for Ukraine's military sensor data.

Implementation of a ministerially accepted 3 per cent uplift for senior NHS managers remains held back pending a review of how far performance-linked exclusions should extend.

How Scotland’s regional data centres prioritize American cloud giants over public healthcare infrastructure.

Ireland's structured approach to scaling digital pathways exposes the evidential gaps in England's own virtual ward expansion.

How a near-affordable oral GLP-1, private-only until at least November, is likely to widen the gap between what patients can buy and what their local NHS will fund.

The legal fight over sleep accuracy could have consequences far beyond consumers, including NHS observational studies, digital biomarkers and the future of wearable-led research.